Deciding about another operation: Breast Implant Revision: Do I Need It?

Do I need another operation?

Why do people get breast implant revision?

Breast implant revision can change implant size or fill, repair the pocket or address an implant complication, according to ASPS guidance checked October 13, 2026. Implant exchange, also called revision breast augmentation, may involve more than replacing the device. ASPS says there is no standard revision operation; the plan should match the reason you want surgery.

Start by naming what bothers you now. You may want less volume after years of living with implants, a softer breast, an implant that stays in place or an explanation for a new change. Those goals deserve separate answers. FDA defines malposition as the implant sitting in the wrong position and rippling as wrinkles visible or felt through skin. A tight capsule, a displaced implant and sagging breast tissue can overlap in appearance, so photographs alone cannot select your operation. ASPS describes examining the existing implants, taking photographs and discussing options and risks at consultation. Its candidate guidance lists physical health, stable weight, realistic expectations and nonsmoking, without a revision-specific age or weight threshold. Bring your medical conditions, allergies, medicines, supplements and previous surgery history. These are patient-guidance descriptions, not a cohort with a measured success percentage. If you are still deciding about a first augmentation, the separate augmentation guide explains that earlier decision.

Go deeperBreast augmentation candidacy

Do I need another operation?

Is breast implant revision needed every 10 years?

Breast implant revision is not automatically required every 10 years: FDA’s January 31, 2025 page says implant life varies by person and cannot be predicted. FDA also says breast implants are not lifetime devices and later removal or replacement becomes more likely with time. Neither statement sets a universal replacement anniversary.

An implant can need attention before an anniversary, and reaching an anniversary does not by itself diagnose failure. Ask for a decision based on the device you have, symptoms, examination and appropriate imaging. Sientra’s patient label states, “Breast implants are not considered lifetime devices.” That wording also gives no automatic ten-year replacement instruction. Keep manufacturer warranty language separate. MENTOR’s current US summary describes lifetime device replacement for qualifying rupture or deflation; Natrelle describes lifetime replacement for qualifying gel rupture; Motiva’s current program describes lifetime replacement for qualifying rupture and BIA-ALCL. Those are conditional benefits, not promises that a device lasts forever or instructions to replace a healthy implant when a financial benefit ends. MENTOR says implants placed before January 1, 2021 retain the warranty offered at the original surgery. Today’s headline terms therefore cannot be assumed to cover an older operation. FDA links implant-specific labels and requires a patient decision checklist and device card. Ask to read the label for your proposed replacement. The relevant number here is time since implantation per device, not the percentage of patients who require surgery at exactly ten years. The sources give no such deadline-based patient rate.

Choose the repair

Can breast implant revision make implants smaller?

Breast implant revision can use smaller implants, but The Aesthetic Society says downsizing may also require sutures to reduce the pocket and possibly a lift in guidance checked October 13, 2026. ASPS also lists increasing size and changing saline to silicone. A size exchange can therefore change the supporting operation as well as the device.

Explain your goal in ordinary terms, such as less weight, less upper fullness or a shape that fits your clothes. Ask the surgeon to translate it into implant dimensions and the work your tissues need. The Society says a larger replacement may require enlarging the pocket; smaller is not simply the reverse of larger when the skin and old pocket have stretched. Chasan and Francis described capsulorrhaphy for pocket reduction in a 2008 series of 75 cosmetic revision patients. That is a description of a repair in selected patients, not a formula linking implant volume to bra cup size. FDA says both saline and silicone gel implants have silicone outer shells. Choosing between fills also means understanding surveillance and the specific replacement label. Ask what would happen to the existing pocket, whether the capsule needs treatment and whether loose skin would remain. You can want a different size without having a complication. Conversely, changing the size alone may leave the original reason for pain or malposition unresolved. Compare the complete proposals rather than only the new implant’s volume.

Choose the repair

When does capsular contracture need breast implant revision?

Breast implant revision is usually considered for clinically significant Baker III or IV capsular contracture, while Denney and colleagues’ 2021 review describes conservative treatment as the mainstay for Baker II. FDA says severe contracture may need reoperation and can recur. Neither source supplies a universal deadline for surgery.

The capsule is the scar tissue your body forms around an implant. Denney’s review distinguishes a normal thin, soft capsule from contraction that causes symptoms or distorts the breast. FDA’s December 2023 risks page describes four Baker grades. Grade I feels normally soft and looks natural. Grade II feels a little firm but looks normal. Grade III feels firm and looks abnormal. Grade IV is hard, painful and looks abnormal. These grades describe findings; they are not stages everyone inevitably passes through. The review says diagnosis rests largely on history and examination, and discusses proposed mechanisms including biofilm or infection, trauma, rupture and fluid collections. Those possibilities cannot identify the cause in your breast or assign fault to a previous surgeon. New hardness, pain or a shape change should be assessed by your surgical team rather than graded from an online photograph. Ask which findings actually justify capsule surgery, whether rupture testing is needed and what observation would involve if symptoms are mild. A video explanation of prevention is not evidence that you can prevent recurrence yourself with massage or medication.

Choose the repair

Does breast implant revision need capsulectomy?

Breast implant revision does not always require total capsulectomy: Denney and colleagues’ 2021 review distinguishes releasing the capsule from removing it and says removal’s benefit must outweigh its added tissue trauma. Capsulotomy opens or releases the capsule; capsulectomy removes part or all of it. Ask which problem the proposed capsule step treats.

The Breast Surgery Collaborative Community consensus, checked October 13, 2026, uses precise terms. Partial capsulectomy leaves some capsule. Total capsulectomy removes the entire capsule but need not remove it in one piece. Total intact capsulectomy removes it as one unit. En bloc additionally includes a margin of uninvolved tissue and has a different cancer-related purpose. BSCC identifies suspected or established implant-associated cancer after appropriate workup as the only absolute indication for en bloc capsulectomy. Contracture, rupture and an abnormal capsule can be reasons to consider capsule removal individually. Denney’s review notes hematoma and pneumothorax risks with capsulectomy. The comparative evidence does not resolve every choice: a 2024 systematic review contained 34 observational studies after a November 2021 search, and a 2023 conference meta-analysis of 21 papers found no randomized trial or statistically significant recurrence difference between capsulotomy and capsulectomy. That does not establish equivalence. BSCC also says whether capsulectomy prevents future implant-associated cancer is unknown. More extensive capsule removal therefore needs a specific explanation of benefits, risks and what would be left behind.

Will it work this time?

Can capsular contracture return after breast implant revision?

Capsular contracture can return after breast implant revision: Swanson’s 2016 Kansas series reported recurrence in 17 of 75 women, or 22.7%, after open capsulotomy with mean follow-up of 2.8 years. This was one selected practice series, predominantly involving saline implants. It is not a recurrence estimate for every capsule operation.

The series covered operations during 1996–2016, with ages 18.6–71 at first capsulotomy. It excluded reconstruction and extensively calcified capsules treated by capsulectomy. Most existing above-muscle pockets changed to below-muscle pockets, so the result cannot isolate release alone. Two women in the original 75-person group had a second recurrence; the denominator for a repeat-treatment subgroup is different. A separate 2020 New York report by Hidalgo and Weinstein evaluated 217 treatments in 180 patients, including 185 conventional and 32 ADM treatments. Its Table 3 defined success as Baker II or better and reported 71.4% and 96.9%, respectively. Those are treatment-level results in selected, nonrandomized groups, not recurrence probabilities for independent adult patients. Clinical follow-up averaged thirteen months for conventional treatment and fifteen months for ADM; a longer headline average included later telephone contact with 89 of 180 patients. ADM was adopted toward the end and selected for difficult cases. Ask how your surgeon distinguishes persistent firmness, a new contracture and another operation, and whether their follow-up captures patients who seek subsequent care elsewhere.

Choose the repair

Can breast implant revision fix bottoming out or shifting?

Breast implant revision can repair a displaced implant by adjusting its existing pocket or creating a new one, according to Denney and colleagues’ 2021 review. Bottoming out, lateral displacement, symmastia and double bubble describe different positions. Capsulorrhaphy uses pocket-tightening sutures; selected repairs may also need reinforcement or a plane change.

In bottoming out, the review describes loss of lower-pole support after disruption of the inframammary fold, increasing the distance from nipple to fold and leaving the nipple relatively high. Lateral displacement means the implant sits too far toward the side; the review associates it with an overly wide lateral pocket. Symmastia involves medial displacement across the midline after disruption of the intermammary sulcus. Double bubble describes two parallel folds, the original fold above and the descended implant level below. High-riding implants are another pattern and must be distinguished from contracture or breast ptosis. The diagnosis matters because tightening the wrong part of a pocket would not explain the original problem. The Aesthetic Society describes sutures and selected ADM reinforcement for malposition. A 2016 review found 21 malposition studies, all level IV or V, so these descriptions do not establish one superior repair or a dependable repair-specific recurrence percentage. Ask the surgeon to mark which pocket boundary has failed, where they plan to move it and whether your implant size still fits the intended space.

Choose the repair

Can breast implant revision fix animation deformity?

Breast implant revision can change the pocket to address muscle-driven distortion, but Denney and colleagues’ 2021 review says adequate tissue coverage matters when moving an implant from below to above the pectoral muscle. The Aesthetic Society explains that an implant under pectoralis may move when the muscle flexes. This movement is the issue commonly called animation deformity.

Show the surgeon the movement that bothers you, including during a chest contraction, rather than relying only on a still photograph. The review distinguishes adjusting an existing pocket from making another one. An above-muscle location removes that particular muscle interaction but changes the amount of tissue between the implant and skin. Ask about visible edges or rippling if your coverage is thin. A 2010 UCLA/UT Southwestern report describes below-to-above-muscle conversion with muscle resuspension for unwanted movement and malposition in 36 patients, with average follow-up of twenty months. It is a retrospective aesthetic revision series, not a universal success rate. A separate 2008 technical report describes a neopectoral pocket that preserves muscle coverage while controlling pocket size; the name alone does not tell you whether it fits your anatomy. These are different maneuvers with different trade-offs. Ask the surgeon to draw your present pocket and the proposed pocket on the same cross-section, then explain what happens to the old capsule and muscle. A change in plane can accompany exchange, but exchanging the device alone does not describe that work.

Will it work this time?

Does breast implant revision need mesh or an internal bra?

Breast implant revision may use acellular dermal matrix (ADM) or mesh when native tissue is insufficient, but Denney and colleagues’ 2021 review lists added cost, infection, inflammation, seroma and malposition among ADM’s disadvantages. An internal bra is a description that needs the actual material and repair named. The evidence does not establish that every revision needs support.

ADM and synthetic or biologic scaffolds should not be treated as interchangeable products. Ask for the proposed material’s name, why your own capsule and tissues are insufficient and the current regulatory status of that specific use. Denney’s 2021 review called GalaFLEX use in revision breasts off-label at that time; that dated statement is not a current clearance ruling for every product. A 2019 early GalaFLEX report contained five patients and called for larger study. A 2024 nonrandomized comparison enrolled 50 adults with Baker III/IV contracture after augmentation, treating 89 breasts during 2016–2023. All 59 OviTex-treated breasts were postoperative Baker I/II; one of 30 Strattice-treated breasts was Baker III. Mean follow-up was 357 days, and lifts, capsule surgery and plane changes also occurred. This postoperative grade result cannot isolate material benefit or separate persistent from newly recurrent contracture. Pacella disclosed investigator/lecturer work for TELA Bio; the paper says the company supplied no study funding or product. A 2025 P4HB review mixed several aesthetic and reconstructive operations, so its pooled satisfaction cannot answer revision-only success.

Choose the repair

Can breast implant revision fix rippling with fat grafting?

Breast implant revision can address rippling by changing implant type or tissue coverage, with fat grafting as a possible soft-tissue adjunct, according to The Aesthetic Society and Denney and colleagues’ 2021 review. FDA defines rippling as implant wrinkles visible or felt through skin. These sources do not provide a universal fat-survival percentage or promise complete concealment.

Ask whether what you see is a folded implant edge, inadequate coverage, displacement or more than one issue. The Society describes repositioning the implant or changing the implant type or pocket when edges are visible or palpable. Denney’s review places fat grafting alongside capsule, pocket and lift decisions rather than presenting it as a substitute for every structural repair. If fat is proposed, ask where it would be placed, what contour it is meant to soften and whether the surgeon expects another session. The verified sources used here do not establish a reliable number of sessions for your anatomy. Sientra’s core label reports a ten-year Kaplan–Meier rippling estimate of 4.8% among 363 revision-augmentation enrollees with mixed historical smooth/textured and round/shaped devices. That is an estimate of an event after revision in that study, not the success rate of fat grafting. Follow-up was incomplete, and the label reports 62% attendance among patients expected at the ten-year visit, not among every original enrollee. Keep those denominators separate when asking whether a particular repair is likely to improve your concern.

Choose the repair

When does breast implant revision need a breast lift?

Breast implant revision may need a concurrent breast lift when implant exchange alone will not address excess skin or nipple position, according to ASPS and The Aesthetic Society guidance checked October 13, 2026. The Society specifically notes that downsizing may require a lift. Replacing an implant and lifting the breast treat different parts of the problem.

Ask the surgeon to distinguish where the implant sits from where your own breast tissue and nipple sit. Denney’s 2021 review discusses replacement with mastopexy for aging or ptotic augmented breasts; a new device alone does not necessarily correct stretched skin. The Society says nipple/areola elevation can need additional lift incisions. ASPS lists inframammary, peri-areolar and vertical or Wise-pattern lift incisions depending on the procedures performed. Reusing an old implant scar therefore does not describe every combined revision. A 2012 Newport Beach technical algorithm involving 264 revision augmentation or revision mastopexy-augmentation patients emphasizes previous incisions and nipple-areola blood supply. That is planning evidence, not a universal combined-operation risk percentage. Ask how your previous scars affect the proposed lift, whether both sides need the same pattern and what would remain if you chose exchange alone. The dedicated breast lift guides explain lift candidacy, scars, cost and recovery in detail; use them alongside the revision plan so your quote and time-off discussion include the combined work rather than exchange alone.

Go deeperBreast lift candidacy Breast lift cost Breast lift recovery

Do I need another operation?

How is rupture checked before breast implant revision?

Breast implant revision planning for possible silicone rupture may require imaging because most silicone ruptures are silent, according to FDA’s December 2023 risks page. FDA’s September 2020 guidance recommends ultrasound or MRI at 5–6 years after silicone implantation and every 2–3 years afterward for asymptomatic patients. Symptoms or an equivocal ultrasound warrant MRI at any postoperative time.

FDA describes saline deflation as partial or complete collapse after leakage through a valve or shell defect. Its guidance supplies no routine saline rupture-screening schedule because deflation can be detected without screening. Silicone gel may remain inside the surrounding capsule after shell rupture or escape outside it; FDA says escaped gel can be difficult to remove. Examination alone may miss a silent rupture. Shape or size changes, hard lumps, asymmetry, pain, tenderness or sensory symptoms can occur, but symptoms do not establish the diagnosis. Contact your healthcare provider when a new change appears and ask which examination or imaging is appropriate rather than waiting for the next routine interval. The surveillance schedule is per asymptomatic silicone-implant patient and is guidance, not a measured percentage or a replacement deadline. It also does not replace mammography or other imaging required by your history. Bring previous images and reports so the revision surgeon can explain whether a rupture is suspected, confirmed and contained, and how that affects capsule treatment and exchange. Historical device labels may show older schedules; ask which current instructions apply to your device.

Do I need another operation?

Do textured implants need breast implant revision?

Breast implant revision is not routinely recommended solely for BIA-ALCL concern in patients without symptoms, according to FDA’s October 23, 2019 Q&A. FDA says risk is higher with textured than smooth implants. The July 24, 2019 Allergan recall covered BIOCELL textured implants and expanders, while the announcement says smooth and MICROCELL products were not affected.

BIA-ALCL is a non-Hodgkin lymphoma of the immune system generally found in fluid or scar capsule near the implant, rather than breast tissue. FDA names persistent swelling, a mass or pain, often years after placement, as symptoms that need healthcare-provider evaluation. Testing can change the operation; FDA describes fluid/tissue pathology including CD30 and ALK assessment, and says confirmed BIA-ALCL requires implant and surrounding capsule removal. Ask for the device card or operative record to identify your model. FDA’s passive reports through June 30, 2024 cannot establish incidence because device-use denominators and histories are incomplete. ASPS separately prints an estimated lifetime textured-implant range of 1:2,207–1:86,029, based on confirmed cases and sales over two decades; this is not FDA’s figure or your brand-specific US probability. ASPS says no confirmed cases involve only smooth implants, while FDA discusses a smooth-device report without a known textured history and many incomplete histories. Neither supports claiming zero risk. ASPS’s February 2024 response supports FDA guidance and individual discussion; it critiques a preventive-benefit inference drawn from 248 affected cases without noncase controls. BSCC says capsulectomy’s cancer-prevention effect remains unknown.

Do I need another operation?

How long should I wait before breast implant revision?

Breast implant revision for an elective size change is often deferred until healing has settled: a 2022 ASPS-hosted author says most doctors recommend about a year after the first operation. That is an author’s guidance, not a rule for infection, suspected rupture or new concerning symptoms. The reason for revision determines what evaluation should happen now.

ASPS says swelling can initially obscure revision results, gives at least six weeks for swelling to resolve and the breasts to soften, and says some breasts take 6–12 months to feel normal. These are counseling intervals without a measured recovery distribution, not permission to ignore a change for that long. The Aesthetic Society says new implants may take weeks or months to settle, and extreme or prolonged pain warrants surgeon contact. FDA says persistent swelling, a mass or pain around an implant needs evaluation, and an infection may require implant removal if antibiotics fail. After surgery, ASPS says shortness of breath, chest pain or unusual heartbeats warrant immediate medical attention. Before an elective revision, ASPS lists health, stable weight, nonsmoking and realistic expectations, with medical evaluation and medication review as needed. Coordinate any medicine changes with your surgical and prescribing teams. If observation is proposed, ask what the surgeon is watching, how it will be documented and which changes should prompt an earlier call. The recovery guide covers activity and practical support after your particular repair; a settling estimate cannot clear you for another operation.

Will it work this time?

What are the risks of breast implant revision?

Breast implant revision carries bleeding, infection, fluid collection, wound, sensory, anesthesia and aesthetic risks, according to ASPS guidance checked October 13, 2026. ASPS gives no procedure-specific probabilities on that page. Long-term device studies show repeat operations occur, but their percentages describe particular cohorts rather than your personal odds.

MENTOR’s 2021 MemoryGel study enrolled 145 US revision-augmentation patients, ages 20–63, with 64% ten-year follow-up. Table 2 gives ten-year Kaplan–Meier estimates of 43.7% for any reoperation, 21.03% for implant-related reoperation, 24.4% for Baker III/IV contracture and 1.4% for infection. The abstract instead prints 43.6% for any reoperation; we preserve the table’s endpoint. Historical smooth and SILTEX devices and manufacturer funding limit transfer. Sientra’s core label includes 363 revision enrollees; its ten-year estimates are shown separately below. It reports 62% attendance among those expected at the ten-year visit, with that expected count not supplied in the passage. Motiva’s 2024 report covers 109 US revision patients, 218 implants, with 88.7% three-year follow-up. It counts 29 reoperations in 27 patients, or 24.8% raw, alongside a 25.8% KM estimate. Its 28.4% complication estimate, involving 30 patients, excludes mild events except specified categories; it is not an all-severity rate. ADM/scaffold use was prohibited. These different devices, eras and follow-up periods cannot rank brands. Ask separately about permanent sensation changes, skin loss, persistent pain, asymmetry, recurrent looseness and another operation.

Plan the consultation

How do I choose a breast implant revision surgeon?

Breast implant revision should be planned with a surgeon experienced in the breast operations you need, and ASPS’s checklist specifically asks about American Board of Plastic Surgery certification. ABMS identifies ABPS as its plastic-surgery specialty board in sources checked October 13, 2026. A medical license, society membership and specialty board certification are separate credentials.

You can consult the original surgeon or another surgeon. Bring the same records and questions to either visit; a need for revision alone does not establish why a problem occurred or fault. ASPS says no ABMS-recognized certifying board has cosmetic surgery in its name, so ask which board an unspecified board-certified description means. Ask about relevant revision experience, hospital privileges, facility accreditation, follow-up access and options if you remain dissatisfied. FDA says your device card or operative records identify the implant; Denney’s 2021 review recommends previous surgeons’ notes and discussing unexpected findings before surgery. For breast implant revision before and after photos, start with Afters’ breast augmentation gallery and ask the practice to identify actual revision cases. It is a broader augmentation collection, not a verified revision-only gallery. Compare patients with the same starting problem, procedures and follow-up time; selected images cannot establish success or recurrence rates. Ask whether a lift, fat grafting or support accompanied the exchange and whether later surgery occurred. ASPS lists implants, surgeon, facility, anesthesia, tests and other costs separately and says warranties may cover some costs in some instances. Request that scope in writing before comparing quotes.

Go deeperBreast augmentation before and after photos Cosmetic surgery financing